The investment is a booster shot to South Africa’s ailing manufacturing sector. The move is part of Pfizer’s partnership with the Biovac Institute.
“We have been working with Biovac to get the site up and running so we can start manufacturing the pneumococcal vaccine, between one and three million doses annually. It is really to vaccinate children as part of the expanded programme for immunisation in South Africa,” Van der Loo said.“This is one of the two sites outside the normal multinational company network chosen to manufacture the Covid-19 vaccine.
Vaccines are no cure. The Oligarchs orchestrated this long ago for stupid people all over the world to follow the lie, mass murder. This is BS!
Africa does not need them.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: